Mon Nov 23, 2009
UCLA Health System Research and Education: David Geffen School of Medicine at UCLAPatient Care: UCLA Health System
UCLA Urology
Home
For Patients
About Us
Appointments
Innovations and Technology
Newsletters
Webcasts - Urology
News and Events
Events
Maps and Directions
Academic Information
SPORE In Prostate Cancer
How You Can Help
Resources and Publications
Contact Us
Sitemap
Intranet



Request an Appointment

Phone: (310) 794-7700

Visiontree optimal care
patient registration

UCLA Urology #4 in the Nation Highest Ranked in California
UCLA Urology
#4 in the Nation
Highest Ranked in California

Increase (+) Default Decrease (-) Font Size

News and Events

News - Urology at UCLA

The UCLA Department of Urology provides cutting edge diagnosis and treatments, and supports a staff of renowned physicians, surgeons and researchers.

Demonstrating continued excellence in the field of Urology, the UCLA Department of Urology along with its varied Centers of Excellence, is often the subject of stories in newspapers, magazines, and journals. The Department also frequently issues news releases to keep the community informed on the latest developments in urology, the treatments available at UCLA, and various milestones within the Department. Here we present a collection of recent stories, and an archive of older articles, for your further information.


Updates for Prostate Cancer PatientsUpdates for Prostate Cancer Patients

October 27, 2009
This is the second in a series of updates from the UCLA Department of Urology and the SPORE in Prostate Cancer on the latest treatments and research for prostate cancer. Scheduled topics include hypofractionated stereotactic radiotherapy for prostate cancer, the new Radiation Oncology program, and the latest developments in prostate cancer. Speakers include Chris King, MD, PhD (Radiation Oncology) and Robert Reiter, MD (Urology). This event is open to the public; however, guests are asked to RSVP by October 26th. Please contact Lauren Whitted at (310) 794-1397 or lwhitted@mednet.ucla.edu for more information.
View PDF version >>


Surgeon's Preferences Dictate Choice of Kidney Cancer SurgerySurgeon's Preferences Dictate Choice of Kidney Cancer Surgery

March 12, 2008
(HealthDay News) -- A surgeon's skills and preferences may dictate treatment choices for kidney cancer more than clinical factors such as tumor size or the patient's general health, a new study finds.
Link to complete article >>
View PDF version >>


Kidney Cancer Surgeons Snub Innovations and Stick to Old WaysKidney Cancer Surgeons Snub Innovations and Stick to Old Ways

March 12, 2008
For kidney cancer patients, surgeons have been slow to adopt innovative procedures with apparent advantages, researchers here found. The newer techniques of nephron-sparing surgery or laparoscopic radical nephrectomy have advantages over the traditional method of open radical nephrectomy, but surgeons are slow to adopt the practices, David Miller, M.D., M.P.H., of the University of California Los Angeles, and colleagues reported online in Cancer. The study results are slated to appear in the April 15 print issue.
Link to complete article >>
View PDF version >>


Kidney Cancer Surgery Often Determined By Surgeons' Practice Style, Not Medical Factors, Study ShowsKidney Cancer Surgery Often Determined By Surgeons' Practice Style, Not Medical Factors, Study Shows

March 12, 2008
ScienceDaily (Mar. 10, 2008) — A new study reveals that the type of surgery a patient with kidney cancer receives depends more on the surgeon's preference than on the patient's tumor size, demographic characteristics, or general medical health. The findings indicate that patients with kidney cancer often may not be receiving the most appropriate surgical care
Link to complete article >>
View PDF version >>


UCLA Medical Center Performs Its First Living Donor Kidney “Swap”UCLA Medical Center Performs Its First Living Donor Kidney “Swap”

September 25, 2007
UCLA Medical Center on Sept. 20 performed its first living donor kidney "swap," a procedure in which a loved one of a kidney transplant patient who is not compatible as a donor exchanges organs with another incompatible pair under an innovative new paired donation program. UCLA aims to lead the way for other Southern California transplant centers to adopt this life-enhancing procedure.
Link to complete article >>
View PDF version >>


Urologic Diseases Cost Americans $11 Billion a YearUrologic Diseases Cost Americans $11 Billion a Year

May 1, 2007
By Medicare Pays Half
Bladder, prostate and other urinary tract diseases cost Americans nearly $11 billion a year, according to a new report from the National Institutes of Health. Medicare’s share exceeded $5.4 billion.
Link to complete article >>
View PDF version >>


Diet’s Effect on Prostate Cancer Draws Wide CoverageDiet’s Effect on Prostate Cancer Draws Wide Coverage

August 4, 2006
Balancing Fats May Help Prostate Cancer
Link to complete article >>
View PDF version >>

By Altering Fatty Acid Intake May Help Fight Prostate Cancer
Health Day News and Ivanhoe reported August 1, and Reuters Health and United Press International reported August 2 on new animal research showing that altering the typical Western diet to include more omega-3 fatty acids and less omega-6 fatty acids may reduce prostate tumor growth rates and PSA levels. The study was published August 1 in Clinical Cancer Research. Dr William Aronson, profesor of urology and researcher with jonsson Cancer Cetner, was quoted. The Health Day report also appeared in Forbes.com. The Reuters Health story was picked up by Health Sentinel.com, Gulf News.com, Trade Arabia.com and Cancer Page.com. Other Web coverage included eMaxHealth.Health24, Food Navigator, Best Syndication, News Target (Taiwan) and MedIndia.


NIH Awards to Medical Schools by RankNIH Awards to Medical Schools by Rank

July 11, 2005
By 2004 Fiscal year top awardee - DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA
DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA ranks #1 in NIH awards for research in 2004. See published list:
Link to complete article >>
View PDF version >>


abc NEWS: Having a partner helps men with prostate cancerabc NEWS: Having a partner helps men with prostate cancer

May 23, 2005
By REUTERS Health
By Alison McCook

MEN WITH SPOUSES, PARTNERS FARE BETTER AFTER TREATMENT FOR PROSTATE CANCER THAN SINGLE MEN, UCLA STUDY FINDS Being married or in a relationship significantly improves quality of life for prostate cancer patients following treatment, according to a study by researchers at UCLA’s Jonsson Cancer Center and the Department of Urology. For more information on the Jonsson Cancer Center, visit our web site at http://www.cancer.ucla.edu/.
View PDF version >>


CANCER News AlertCANCER News Alert

May 11, 2005
By Relationships Improve Quality of Life for Prostate Cancer Patients
The social support provided by having a partner significantly improves the quality of life of prostate cancer patients, according to a study published in the July 1, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society. Researchers say men with prostate cancer who are in a relationship report significantly better psychosocial and spiritual well-being and fewer disease-specific and general cancer-related adverse effects. In fact, partnered men were better able to tolerate symptoms related to their disease and treatment.
View PDF version >>


UCLA Researchers Examine Impact of Urologic Diseases on American PublicUCLA Researchers Examine Impact of Urologic Diseases on American Public

July 13, 2004
UCLA Researchers Will Team With RAND and VA For Comprehensive Analysis.
UCLA and RAND researchers have launched a first-of-its-kind study to document the impact of urologic diseases on the American public, an endeavor that may influence insurance coverage, access to care, the allocation of research dollars and the availability of treatments and services.
Link to complete article (PDF) >>
View Publication (PDF) >>


Adjuvant Clinical Trial to Prevent the Recurrence and Progression of Bladder CancerAdjuvant Clinical Trial to Prevent the Recurrence and Progression of Bladder Cancer

May 14, 2004
UCLA Department of Urology, the National Cancer Institute Division of Cancer Prevention, Genentech/OSI Pharmaceuticals, and Tokyo Food Techno Announce First of it’s Kind Adjuvant Clinical Trial to Prevent the Recurrence and Progression of Bladder Cancer.
Link to complete article (PDF) >>


Back to Top